SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-17-000131
Filing Date
2017-11-30
Accepted
2017-11-30 16:51:19
Documents
3
Period of Report
2017-11-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kconsobmonthly2017.htm 8-K 40301
2 EXHIBIT 99.1 ex991consobmonthly2017.htm EX-99.1 42088
3 ctilogoa32.jpg GRAPHIC 5054
  Complete submission text file 0000891293-17-000131.txt   90740
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 171231724
SIC: 2834 Pharmaceutical Preparations